A review of IoT systems to enable independence for the elderly and disabled individuals
Recent years have witnessed an increase in human life expectancy fueled by significant
improvements in infrastructure, healthcare, and economies across the globe. Longer life …
improvements in infrastructure, healthcare, and economies across the globe. Longer life …
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
K Benhalima, K Beunen, SE Siegelaar… - The Lancet Diabetes & …, 2023 - thelancet.com
Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle,
and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre …
and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre …
Recent development of drug delivery systems through microfluidics: From synthesis to evaluation
Z Ma, B Li, J Peng, D Gao - Pharmaceutics, 2022 - mdpi.com
Conventional drug administration usually faces the problems of degradation and rapid
excretion when crossing many biological barriers, leading to only a small amount of drugs …
excretion when crossing many biological barriers, leading to only a small amount of drugs …
Basal Glucose Control in Type 1 Diabetes Using Deep Reinforcement Learning: An In Silico Validation
People with Type 1 diabetes (T1D) require regular exogenous infusion of insulin to maintain
their blood glucose concentration in a therapeutically adequate target range. Although the …
their blood glucose concentration in a therapeutically adequate target range. Although the …
[HTML][HTML] Experiences of young people and their caregivers of using technology to manage type 1 diabetes mellitus: systematic literature review and narrative synthesis
N Brew-Sam, M Chhabra, A Parkinson, K Hannan… - JMIR …, 2021 - diabetes.jmir.org
Background: In the last decade, diabetes management has begun to transition to technology-
based care, with young people being the focus of many technological advances. Yet …
based care, with young people being the focus of many technological advances. Yet …
An insulin bolus advisor for type 1 diabetes using deep reinforcement learning
(1) Background: People living with type 1 diabetes (T1D) require self-management to
maintain blood glucose (BG) levels in a therapeutic range through the delivery of exogenous …
maintain blood glucose (BG) levels in a therapeutic range through the delivery of exogenous …
Automated insulin delivery for pregnant women with type 1 diabetes: where do we stand?
K Benhalima, J Jendle, K Beunen… - Journal of diabetes …, 2024 - journals.sagepub.com
Automated insulin delivery (AID) systems mimic an artificial pancreas via a predictive
algorithm integrated with continuous glucose monitoring (CGM) and an insulin pump …
algorithm integrated with continuous glucose monitoring (CGM) and an insulin pump …
Randomized controlled trial of mobile closed-loop control
B Kovatchev, SM Anderson, D Raghinaru… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE Assess the efficacy of inControl AP, a mobile closed-loop control (CLC) system.
RESEARCH DESIGN AND METHODS This protocol, NCT02985866, is a 3-month parallel …
RESEARCH DESIGN AND METHODS This protocol, NCT02985866, is a 3-month parallel …
Outpatient randomized crossover comparison of zone model predictive control automated insulin delivery with weekly data driven adaptation versus sensor …
JE Pinsker, E Dassau, S Deshpande… - Diabetes technology …, 2022 - liebertpub.com
Background: Automated insulin delivery (AID) systems have proven effective in increasing
time-in-range during both clinical trials and real-world use. Further improvements in …
time-in-range during both clinical trials and real-world use. Further improvements in …
[HTML][HTML] Review of automated insulin delivery systems for individuals with type 1 diabetes: tailored solutions for subpopulations
Automated insulin delivery (AID) systems have proven safe and effective in improving
glycemic outcomes in individuals with type 1 diabetes (T1D). Clinical evaluation of this …
glycemic outcomes in individuals with type 1 diabetes (T1D). Clinical evaluation of this …